FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KRAEUTLER JOHN A 		2. Issuer Name and Ticker or Trading Symbol

MERIDIAN BIOSCIENCE INC [ VIVO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman and CEO
(Last)          (First)          (Middle)

3471 RIVER HILLS DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/3/2016
(Street)

CINCINNATI, OH 45244
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  732   I   Held in Meridian Savings & Investment Plan (401K)  
Common Stock                  311683   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)   $19.09   10/3/2016     A      50000   (1)      9/30/2017     (2) Common Stock   50000   $0   50000   D    
Stock Options (Right to Buy)   $19.09   10/3/2016     A      50000   (3)      9/30/2018     (4) Common Stock   50000   $0   50000   D    

Explanation of Responses:
( 1)  This award is made under the 2012 Stock Incentive Plan pursuant to Mr. Kraeutler's Third Amended and Restated Employment Agreement dated October 3, 2016. The options vest in full (or 100%) on September 30, 2017 so long as Mr. Kraeutler is employed by Meridian on such date.
( 2)  These options expire three years from the date of Mr. Kraeutler's retirement.
( 3)  This award is made under the 2012 Stock Incentive Plan pursuant to Mr. Kraeutler's Third Amended and Restated Employment Agreement dated October 3, 2016. The options vest in full (or 100%) on September 30, 2018 so long as Mr. Kraeutler is employed by Meridian on such date.
( 4)  These options expire three years from the date of Mr. Kraeutler's retirement.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
KRAEUTLER JOHN A
3471 RIVER HILLS DRIVE
CINCINNATI, OH 45244 		X
Chairman and CEO

Signatures
/s/ Melissa A. Lueke as Attorney-in-fact for John A. Kraeutler 10/5/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Meridian Bioscience Charts.
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Meridian Bioscience Charts.